Cargando…
Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic Colorectal Cancer
IMPORTANCE: Professional society guidelines recommend treating patients with metastatic colorectal cancer with targeted therapies, including epithelial growth factor receptor (EGFR) inhibitors and vascular endothelial growth factor (VEGF) inhibitors, depending on the presence or absence of certain m...
Autores principales: | Koroukian, Siran M., Booker, Benjamin D., Vu, Long, Schumacher, Fredrick R., Rose, Johnie, Cooper, Gregory S., Selfridge, J. Eva, Markt, Sarah C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857024/ https://www.ncbi.nlm.nih.gov/pubmed/36656585 http://dx.doi.org/10.1001/jamanetworkopen.2022.50030 |
Ejemplares similares
-
Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer
por: Markt, Sarah C., et al.
Publicado: (2022) -
MULTIPLE CHRONIC CONDITIONS IN OLDER CANCER SURVIVORS WITH AND WITHOUT HIV
por: Koroukian, Siran, et al.
Publicado: (2019) -
Incidence of Aggressive End-of-Life Care Among Older Adults With Metastatic Cancer Living in Nursing Homes and Community Settings
por: Koroukian, Siran M., et al.
Publicado: (2023) -
3371 The Devil is in the Details: Unbalanced Gains in Healthcare Access and Affordability in the Health Insurance Exchanges
por: Kim, Uriel, et al.
Publicado: (2019) -
4498 The Effect of the Affordable Care Act on the Stage at Diagnosis in Low income Privately Insured Cancer Patients, including those with Marketplace coverage
por: Kim, Uriel, et al.
Publicado: (2020)